A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
OBJECTIVES:
- Determine the feasibility of Intimacy-Enhancing Couples Therapy (IECT) for patients
with advanced or recurrent prostate cancer and their partners.
- Compare the effect of IECT vs usual care on patients' and their partners' level of
global psychological distress.
- Compare the effect of IECT vs usual care on relationship intimacy in these
participants.
OUTLINE: This is a randomized, controlled, pilot, multicenter study. Patients are stratified
according to marital distress based on partners' scores on the Abbreviated Dyadic Adjustment
Scale (high [< 21] vs low [≥ 21]). Patients and their partners are randomized to 1 of 2
arms.
- Arm I: Patients and their partners receive Intimacy-Enhancing Couples Therapy over 6
weeks comprising the following four 90-minute sessions: the Story of Cancer;
Understanding the Couple, Ways of Relating and Key Influences; Intimacy; and Coping,
Support, and Adaptation. Patients and their partners complete treatment satisfaction
questionnaires after completion of study intervention.
- Arm II: Patients and their partners receive standard psychosocial care. All
participants complete questionnaires assessing psychological distress, intimacy,
communication patterns, and overall relationship adjustment/satisfaction at baseline
and at 1 month after completion of study intervention.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Feasibility of Intimacy-Enhancing Couples Therapy (IECT) (e.g., eligibility rate, acceptance rate, attendance rate, satisfaction) assessed at baseline and at 1 month after completion of study intervention
2 years
No
Talia Zaider, PhD
Study Chair
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
07-043
NCT00483678
April 2007
April 2014
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
Fox Chase Cancer Center - Cheltenham | Philadelphia, Pennsylvania 19111-2497 |